Neuropeptides and gastric mucosal homeostasis

Current Topics in Medicinal Chemistry

Volumn 4, Issue 1, 2004, Pages 63-73

  Gyires, K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Gastric acid secretion; Gastroprotection; Neuropeptides

Indexed keywords

ADRENOMEDULLIN; AMYLIN; BETA ENDORPHIN; BOMBESIN; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DELTORPHIN II; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR AGONIST; NEUROKININ 2 RECEPTOR AGONIST; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OPIATE PEPTIDE; PEPTIDE YY; PROSTAGLANDIN; PROTIRELIN; SOMATOSTATIN DERIVATIVE; TACHYKININ DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; AMYLOID; NEUROPROTECTIVE AGENT; PEPTIDE; TACHYKININ;

CENTRAL NERVOUS SYSTEM; CHOLINERGIC ACTIVITY; DUODENUM ULCER; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; NERVE ENDING; NONHUMAN; PERIPHERAL NERVE; PROSTAGLANDIN RELEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SENSORY NERVE; STOMACH ACID SECRETION; STOMACH FUNCTION; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; ULCEROGENESIS; VAGUS NERVE DORSAL NUCLEUS; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SECRETION; SENSORY NERVE CELL; STOMACH ACID; VAGUS NERVE;

ADRENOMEDULLIN; AMYLOID; ANIMALS; BOMBESIN; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; GASTRIC ACID; GASTRIC MUCOSA; HOMEOSTASIS; HUMANS; NEURONS, AFFERENT; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PEPTIDES; STOMACH ULCER; TACHYKININS; VAGUS NERVE;

EID: 2142763834     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043451609     Document Type: Review

References (133)

1. Long, D.; Leonard, A. M.; Chou, S. N.; Ferench, L. A. Hypothalamus and gastric ulceration. Arch. Neurol. 1962, 7, 167-183.
2. Zhang, J. F.; Zheng, F. The role of paraventricular nucleus of hypothalamus in stress-ulcer formation in rats. Brain Res. 1997, 761, 203-209.
3. Kato, K. L.; Matsuno, Y.; Shimamura, M.; Tanaka, K.; Murai, I.; Imai, S. Role of mucosal prostaglandins in vagally-mediated adaptive cytoprotection in the rat. Gastroenterol. Japn. 1992, 27, 1-8.
4. Tachè, Y.; Yoneda, M. Central action of TRH to induce vagally mediated gastric cytoprotection and ulcer formation in rats. J. Clin. Gatsroenterol. 1993, 17. Suppl. S58-S63.
5. Henagan, J. M.; Smith, G. S.; Seidel, E. R.; Miller, T. A. Influence of vagotomy on mucosal protection against alcohol-induced gastric damage in the rat. Gastroenterology 1984, 87, 903-908.
6. Mózsik, Gy.; Király, A.; Garamszegi, M.; Jávor, T.; Nagy, L.; Sütó, G.; Tóth, Gy.; Vincze, Á. Failure of prostacyclin, β-carotine, atropine and cimetidine to produce gastric and general mucosal protection in surgical vagotomized rats. Life Sci. 1991, 49, 1383-1389.
7. Leslie, R. A. Neuroactive substance in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, are postrema and dorsal motor nucleus of the vagus. Neurochem. Int. 1985, 7, 191-211.
8. Palkovits, M. Neuropeptides and biogenic amines in central cardiovascular control mechanisms. In Central nervous system mechanisms in hypertension. Buckley, J. P.; Ferrario, C. M.; eds. Raven Press: New York, 1981; pp 73-87.
9. Palkovits, M.; Kiss, J. Z.; Beinfeld, M. C.; Williams, T. H. Cholecystokinin in the nucleus of the solitary tract of the rat: evidence its vagal origin. Brain Res. 1982, 252, 386-390.
10. Skofitsch, G.; Hamill, G.S.; Jacobowitz, D.M. Capsaicin depletes corticotropin-releasing factor-like immunreactive neurons in the rat spinal cord and medulla oblongata. Neuroendocrinology 1984, 38, 514-517.
11. Diz, I. D.; Barnes, K. L.; Ferrario, C. M. Functional characteristics of neuropeptides in the dorsal medulla oblongata and vagus nerve. Fed. Proc. 1987, 46, 30-35.
12. Johansson, O.; Hockfelt, T.; Pernow, B., Jeffcoate, S. L.; White, N.; Steinbusch, H. W. M.; Verhofstad, A. A. J.; Emson, P. C.; Spindel, E. Immunhistochemical support for three putative transmitter in one neuron: coexistence of 5-hydroxytriptamine, substance P- and thyreotropin-releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neurosci. 1981, 6, 1857-1881.
13. Lewis, M. W.; Travagli, A. R. Effects of substance P on identified neurons of rat dorsal motor nucleus of the vagus. Am. J. Physiol. 2001, 281, G164-G172.
14. Palkovits, M. Interconnection between the neuroendocrine hypothalamus and the central autonomic system. 1999, 20, 270-295.
15. Berthould, H. R.; Neuhuber, W. L. Functional and chemical anatomy of the afferent vagal system. Auton. Neurosci. 2000, 85, 1-17.
16. Bielefeldt K.; Ozaki N.; Gebhart G. F. Mild gastritis alters voltage-sensitive sodium currents in gastric sensory neurons in rats. Gastroenterology 2002, 122, 752-761.
17. Bielefeldt K.; Ozaki N.; Gebhart G. F. Experimental ulcers alter voltage-dependent sodium currents in rat gastric sensory neurons. Gastroenterology 2002, 122, 394-405.
18. Maggi, C. A. Tachykinins and calcitonin gene-related peptides (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol. 1995, 45, 198.
19. Holzer, P. Neural emergency system in the stomach. Gastroenterology 1998, 114, 823-839.
20. Kato, H.; Yang, H.; Tache, Y. Role of peripheral capsaicin-sensitive neurons and CGRP in central vagally mediated gastroprotective effect. Am. J. Physiol. 1994, 266, R1610-R1614.
21. Yang, H.; Kawakubo, K.; Tache, Y. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP and NO pathways. Am. J. Physiol. 1999, 277, G555-G562.
22. Guidobono, F.; Coluzzi, M.; Pagani, F.; Pecile, A.; Netti, C. Amylin given by central or peripheral routs inhibits acid secretion. Br. J. Pharmacol. 1998, 125, 23-28.
23. Taché, Y.; Vale, W.; Rivier, J.; Brown, M. Brain regulation of gastric secretion: influence of neuropeptides. Proc. Natl. Acad. Sci. USA 1980, 77, 5515-5519.
24. Yang, H.; Cuttitta, F.; Raybould, H.; Taché, Y. Intrathecal injection of bombesin inhibits gastric acid secretion in the rat. Gastroenterology 1989, 96, 1403-9.
25. Okuma, Y.; Yokotani, K.; Osumi, Y. Sympatho-adrenomedullary system mediation of the bombesin-induced central inhibition of gastric acid secretion. Eur. J. Pharmacol. 1987, 139, 73-78.
26. Lenz, J.H.; Klapdor, R.; Hester, S.E.; Webb, V.J.; Galyean, R.F.; River, J.E.; Brown, M.R. Inhibition of gastric acid secretion by brain peptides in the dog. Role of autonomic nervous system and gastrin. Gastroenterology, 1986, 91, 905-912.
27. Zanelli, J. M.; Starraca-Gasser M., Gaines-Das, R. E.; Guidobono, F. The short term effect of peripherally administered brain-gut peptides on gastric acid secretion in rats. Agents Actions 1992, 35, 122-129.
28. Barracking, G.; Ersparmer, V.; Impicatore, M. The action of bombesin on gastric secretion of the dog and the rat. Br. J. Pharmacol. 1973, 49, 437-444.
29. Varner, A. A.; Modlin, I. M.; Walsh, J. H. High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul. Pept. 1981, 1, 289-296.
30. Lloyd, K. C. K.; Raybould, H. E.; Walsh, J. H. Cholecystokinin inhibits gastric acid secretion through type " A" cholecystokinin receptor and somatostatin in rats. Am. J. Physiol. 1992, 263, 287-292.
31. Ishikawa, T.; Osumi, Y.; Nakagawa, T. Cholecystokinin intracerebroventricularly applied stimulates gastric acid secretion. Brain Res. 1985, 333(1), 197-199.
32. Pendley, C. E.; Fitzpatrick, L. B.; Ewing, R. W.; Molino, B. F.; Martin, G. E. The gastrin/cholecystokinin-B receptor antagonist L-365,260 reduces basal acid secretion and prevents gastrointestinal damage induced by aspirin, ethanol and cysteamine in the rat. J. Pharm. Exp. Ther. 1993, 265, 1348-1354.
33. 5 receptor agonist inhibits gastric acid secretion in rats. Eur. J. Pharmacol. 1996, 296, 153-160.
34. 2 receptors in rats. J. Pharm. Exp. Ther. 1997, 281, 245-252.
35. Vincent. P. Neurotensin receptors: binding properties, transduction pathways, and structures. Cell. Mol. Neurobiol. 1995, 15, 501-512.
36. Karinch, A. M.; Schmidt, G. L.; Kauffman, G. L. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats. Brain Res. 1998, 810, 123-129.
37. Kauffman G.L. Stress, the brain and the gastric mucosa. Am. J. Surgery 1997, 174(3), 271-275.
38. Gue, M.; Junien, J.K.; Reeve, J.R. Jr.; River, J.; Grandt, D.; Taché, Y. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Br. J. Pharmacol. 1996, 118(2), 237-242.
39. Martinez, V.; Rivier, J.; Taché. Y. Peripheral injection of new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats. J. Pharm. Exp. Ther. 1999, 200(2), 629-634
40. Monnikes, H.; Tebbe, J.; Bauer, C.; Lauer, G.; Arnold, R. Microinfusion corticotropin-releasing factor into locus coeruleus/subcoeruleus nuclei inhibits acid secretion via spinal pathways in the rat. Brain Res. 1996, 782 (2), 157-165.
41. Gray, S. T.; Morley, J. Y. Neuropeptide Y: anatomic distribution and possible function in mammalian nervous system. Life Sci. 1986, 38, 389-401.
42. Matsuda, M.; Aono, M.; Moriga, M.; Okuma, M. Centrally administered NPY stimulated gastric acid and pepsin secretion by a vagally mediated mechanism. Regulat. Pept. 1991, 35, 31-41.
43. Yang, H.; Taché, Y. PYY in brain stem nuclei induces vagal stimulation of gastric secretion in rats. Am. J. Physiol. 1995, 268, G943-G948.
44. Eissele, R.; Koop, H.; Arnold, R. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat. Zeitschrift für Gastroenterologie 1990, 28(3), 129-131.
45. Fuse, Y.; Polk, D. H.; Lam, R. W.; Fisher, D. A. Distribution of thyrotropin-releasing hormone (TRH) and precursor peptide (TRH-Gly) in adult rat tissues. Endocrinology 1990, 127, 2501-2505.
46. Taché, Y.; Vale, W.; Brown, M. Thyrotropin-releasing hormone CNS action to stimulate gastric acid secretion. Nature 1980, 287, 149-150.
47. Taché, Y.; Stephens, R. L.; Ishikawa, T. Central nervous system action of TRH to influence gastrointestinal functions and ulceration. Ann. NY. Acad. Sci. 1989, 553, 269-285.
48. Saade, N. E.; Abdallah, L. E.; Barada, K. A.; Atweh, S. F.; Nassar, C. F. Effect of intracerebral injections of VIP on jejunal alanine absorption and gastric acid secretion in rats. Regul. Pept. 1995, 55, 269-276.
49. Nassar, C. F.; Abdallah, L. E.; Barada, K. A.; Atweh, S. F.; Saade, N. E. Effects of intravenous vasoactive intestinal peptide injection on jejunal alanine absorption and gastric acid secretion in rats. Regul. Pept. 1995, 55, 261-267.
50. Chiba, T.; Taminato, T., Kadowaki, S.; Abe, H.; Chihara, K.; Seaino, Y.; Matsukura, S.; Fujita, T. Effects of glucagon, secretin and vasoactive intestinal peptide on gastric somatostatin and gastrin release from isolated perfused rats stomach. Gastroenterology 1980, 79, 67-71.
51. Roze, C.; Dubrasquet, M.; Chariot, J.; Vaille, C. Central inhibition of basal pancreatic and gastric secretion by β-endorphin in rats. Gastroenterology 1980, 79, 659-664.
52. 2-adrenoceptor agonists and β-endorphin in rats. Eur. J. Pharmacol. 2002, 434, 225-229.
53. Intorre, L.; Mengozzi, G.; Vanni, E.; Grassi, F.; Soldani, G. The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs. Eur. J. Pharmacol. 1993, 243, 265-272.
54. 2-opioid receptor agonists on gastric function in the rat. Neuropharmacology 1994, 33, 977-981.
55. Guidobono, F.; Pagani, F.; Ticozzi, C.; Netti, C. Investigation on the mechanisms involved in central protective effect of amylin on gastric ulcers in rats. Br. J. Pharmacol. 1998, 125, 23-28.
56. Takeuchi, K.; Nida, H.; Ohuchi, T.; Okabe, S. Influence of urethane anesthesia on indomethacin-induced gastric mucosal lesions in rats. Regulation to blood sugar levels. Dig. Dis. Sci. 1994, 39, 2536-2542.
57. Taché, Y.; Simard, P.; Collu, R. Prevention of bombesin of cold-restraint stress induced hemorrhagic lesions in rats. Life Sci. 1979, 24, 1719-1726.
58. Giraljeva, C.V.; Lindholm, E.; Novin, D. Physiological and morphological changes in the gastrointestinal tract induced by hypothalamic intervention: an overview. Brain Res. Bull. 1980, 5, 19-31.
59. Hagiwara, M.; Watanabe, H.; Kanaoka, R. Effects of intracerebroventricular bombesin on gastric ulcers and gastric glycoproteins in rats. J. Pharmacobiodyn. 1985, 8, 864-867.
60. Hernandez, D. E.; Burke, J. D.; Orlando, R. C.; Prange, A. J. Differential effects of intracisternal neurotensin and bombesin on stress- and ethanol-induced gastric ulcers. Pharmacol. Res. Commun. 1986, 18, 617-627.
61. Martinez, V.; Taché, Y. Bombesin and brain gut axis. Peptides 2000, 21, 1617-1625.
62. Konturek, S. J.; Brzozowski, T.; Pytko-Polonczyk, J.; Drozdowicz, D. Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. Eur. J. Pharmacol. 1995, 273, 57-62.
63. Mercer, D.W.; Cross, J.M.; Baretto, J.C.; Strobel, N.H.; Russel, D.H.; Miller, T.A. Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandin. Dig. Dis Sci. 1995, 40, 651-660.
64. Scheiman J. M.; Tillner, A.; Pohl, T.; Oldenburg, A.; Angermuller, S.; Gorlach, E.; Engel, G.; Usadel, K. H.; Kusterer, K. Reduction of non-steroidal anti-inflammatory drug induced gastric injury and leukocyte endothelial adhesion by octreotide. Gut 1997, 40, 720-725.
65. Pizzuto, G.; Surgo, D.; Clementi, M.; Marsico, R.; Genso, A.; Materia, A.; Basso, N. Differential effect of stress on gastric somatostatin, prostaglandin E and gastrin release in the rat. Dig. Liver Disease 1997, 29, 143-147.
66. Xing, L.; Karnich, A.M.; Kauffman, G.L. Jr.; Mesolimbic expression of neurotensin receptor during stress-induced gastric mucosal injury. Am. J. Physiol. 1998, 274, R38-R45.
67. Ray, A.; Henke, G.P.; Gulati, K.; Sen, P. The amygdaloid complex, corticotropin releasing factor and stress-induced gastric ulcerogenesis in rats. Brain Res. 1993, 624, 286-290.
68. Shibasaki, Y.; Yamauchi, N.; Hotta, M.; Masuda, A.; Oono, H.; Wakabayashi, I; Ling, N.; Demura, H. Brain corticotropin releasing factor acts as inhibitor of stress-induced gastric erosion in rats. Life Sci. 1990, 47, 925-932.
69. Gunion, M.W.; Kauffman, G.L. Jr; Taché, Y. Intrahypothalamic corticotropin releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats. Am. J. Physiol. 1990, 258, 152-157.
70. Hernandez, D. E.; Nemeroff, C. B.; Orlando, R. C.; Prange, A. J. The effect of centrally administered neuropeptides on the development of stress-induced gastric ulcers in rats. J. Neurosci. Res. 1983, 9, 145-157.
71. Ferri, S.; Arrigo-Reina, R.; Candeletti, S.; Costa, G.; Murari, G.; Speroni, E.; Scoto G. Central and peripheral site of action for the protective effect of opioids of the rat stomach. Pharmacol. Res. Comm. 1983, 15, 409-418.
72. Scoto, G. M.; Parenti, C. Prevention of stress-induced gastric ulcers by μ- and δ-opioid agonists in the rat. J. Physiol.(Paris) 1993, 87, 385-388.
73. Gyires, K.; Müllner, K.; Rónai, A. Z. Activation of central opioid receptors may induce gastric mucosal defense in the rat. J. Physiol. (Paris) 2001, 95, 189-196.
74. Spadaro, C.; Arrigo-Reina, R.; Scoto, G.M. Effects of morphine and Met-enkephalin analogue on gastric lesions induced by indomethacin. Pharmacol. Res. Comm. 1987, 19, 223-230.
75. Tuncel, N.; Erkasap, M.; Sahinturk, V.; Ak, D. D.; Tuncel, M. The protective effect of vasoactive intestinal peptide (VIP) on stress-induced gastric ulceration in rats. Ann. NY. Acad. Sci. 1998, 865, 309-322.
76. Goto, Y.; Taché, Y. Gastric erosions induced by intracisternal thyrotropin-releasing hormone (TRH) in rats. Peptides 1985, 6, 153-156.
77. L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats. Neun. Schmid. Arch. Pharm. 1985, 330, 142-146.
78. Ray, A.; Henke, P. G.; Sullivan, R. M. Effects of intra-amygdalar thyreotropin releasing hormone (TRH) and its antagonism by atropine and benzodiazepines during stress ulcer formation in rats. Pharmacol. Biochem. Behav. 1990, 36, 597-601.
79. Robert, A.; Nezamis J.E.; Lancaster, C.; Hanchar, A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1977, 77, 433-443.
80. Guidobono, F.; Pagani, F.; Ticozzi, C.; Sibilia, V.; Pecile, A.; Netti, C. Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br. J. Pharmacol. 1997, 120, 581-586.
81. Mercer, D. W.; Cross, J. M.; Castaneda, A.A.; Gunter, J.A. Gastroprotective action of bombesin, L-DOPA, and mild irritants: role of prostaglandins and sensory neurons. Surgery 1998, 124, 864-870.
82. Brzozowski, T.; Konturek, P. C.; Konturek, S. J.; Kwiecien, S.; Pajdo, R.; Brzozowska, I.; Hahn, E. G. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat. J. Clin. Gastroenterology 1998, 27, 125-137.
83. Heinemann, A.; Jocic, M.; Peskar, B. M.; Holzer, P. CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am. J. Physiol. 1996, 270, 253-258.
84. Mercer, D. W.; Klemm, K.; Cross, J. M.; Smith, G. S.; Gashman, M.; Miller, T. A. Cholecystokinin-induced protection against gastric injury is independent of endogenous somatostatin. Am. J. Physiol. 1996, 271, G692-G700.
85. Cross, J. M.; Chang, L.; Mercer, D. W. Effects of cholecystokinin on gastric injury and gastric mucosal blood flow. J. Gastroint. Surgery 1998, 2, 198-206.
86. Brzozowski, T.; Konturek, P. C.; Konturek, S. J.; Pajdo, R.; Drozdowicz, D.; Kwiecien, S.; Hahn, E. G. Acceleration of ulcer healing by cholecystokinin: role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul. Pept. 1999, 82, 19-23.
87. Stroff, T.; Plate, S.; Respondek, M.; Müller, K.M.; Peskar, B.M. Protection by gastrin in rat stomach involves afferent neurons, calcitonin gene-related peptide and nitric oxide. Gastroenterology 1995, 109, 89-97.
88. Karmeli, F.; Eliakim, R.; Okon, E.; Rachmilewitz, D. Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats. Dig. Dis. Sci. 1994, 39, 617-625.
89. Gyires, K.; Rónai, A. Z.; Tóth, G.; Darula, Zs.; Fürst, S. Analysis of the role of opioid delta receptors in gastroprotection. Life Sci. 1997,60/1, 1337-1347.
90. Nishimura, E.; Buchan, A. M.; McIntosh, C. H. Autoradiographic localization of μ- and δ-type opioid receptors in the gastrointestinal tract of the rat and guinea pig. Gastroenterology 1986, 91, 1084-1094.
91. Ferri, S.; Speroni, E.; Candeletti, S.; Cavicchini, E.; Romualdi, P.; Govoni, P.; Marchini, M. Protection by opioids against gastric lesions caused by necrotizing agents. Pharmacology 1988, 36, 140-144.
92. Esplugues, J. V.; Whittle, B. J. R.; Moncada, S. Modulation by opioids and by afferent sensory neurons of prostanoid protection of the rat gastric mucosa. Br. J. Pharmacol. 1992, 106, 846-852.
93. Gyires, K.; Rónai, A. Z. Supraspinal delta- and mu-opioid receptors may mediate gastric mucosal protection. J. Pharm. Exp. Ther. 2001, 297, 1010-1015.
94. Taché, Y.; Yoneda, M.; Kato, K.; Király, Á; Sütó, G.; Kaneko, H. Intracisternal thyreotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanism. J. Gastroentrol. Hepatol. 1994, 9, Suppl. 1, S29-S35.
95. Király, Á.; Sütó, G.; Livingston, E. H.; Guth, P. H.; Sr. Pierre, S.; Taché, Y. Central vagal activation by TRH induces gastric hyperemia: role of CGRP in capsaicin-sensitive afferents in rats. Am. J. Physiol. 1994, 267, G1041-G1049.
96. Kato, K.; Yang, H.; Taché, Y. Low dose of TRH act in the dorsal motor nucleus to induce gastric protection in rats. Am. J. Physiol. 1995, 269(38), 1301-1307.
97. Kaneko, H.; Mitsuma, T.; Nagai, H.; Mori, S.; Iyo, T.; Kusugami, K.; Taché, Y. Central action of adrenomedullin to prevent ethanol-induced gastric injury through vagal pathways in rats. Am. J. Physiol. 1998, 274, R1783-1788.
98. Karmeli, F.; Eliakim, R.; Okon, E.; Rachmilewitz, D. Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats. Dig. Dis. Sci. 1993, 38, 1210-1219.
99. Kishimoto, S.; Kobayasi, H.; Shimizu, S.; Kajiyama, G.; Miyoshi, A.; Sakurai, K. Further study of experimental gastritis in rats: endocrine and neuroendocrine profile. J. Clin. Gastroenterology 1993, 17 Suppl 1, S53-57.
100. Guth, P. H.; Paulsen, G.; Nagat, H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology 1984, 87, 1083-1090.
101. Whittle, B. J. R.; Lopez-Belmonte, J.; Moncada, S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interaction with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol. 1990, 99, 607-611.
102. Tanaka, T.; Guth, P.; Taché, Y. Role of nitric oxide in gastric hyperemia induced by central vagal stimulation. Am. J. Physiol. 1993, 264, G280-G284.
103. Yang, H.; Stephens, R. L.; Taché, Y. TRH analogue microinjected into specific medullary nuclei stimulates gastric serotonin secretion in rats. Am. J. Physiol. 1992, 262, G216-G222.
104. Yoneda, M.; Taché, Y. Central thyreotropin-releasing factor analogue prevents ethanol-induced gastric damage through prostaglandins in rats. Gastroenterology 1992, 102, 1568-1574.
105. Holzer, P.; Lippe, I. T. Stimulation of afferent nerve endings by intragastric capsaicin protects against ethanol-induced damage of gastric mucosa. Neuroscience 1988, 27, 981-987.
106. Holzer, P.; Pabst, N. A.; Lippe, I. Th.; Peskar, B. M.; Peskar, B. A.; Livingston, E. H.; Guth, P. H. Afferent nerve-mediated protection against deep mucosal damage in the rat stomach. Gastroenterology 1990, 98, 838-848.
107. Holzer, P.; Livingstone, E. H.; Saria, A., Guth, P. H. Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am. J. Physiol. 1991, 260, G363-G370.
108. Lembeck, F.; Gamse, R. Substance P in peripheral sensory process. In Substance P in the nervous system. Porte, R.; O,Connor M.; eds. Ciba Foundation Symposium 91. Pitman: London, 1982; pp 35-54.
109. Jancsó, G.; Hökfelt, T.; Lundberg, J. M.; Király, E.; Halász, N.; Nilsson, G.; Terenius, L.; Rehfeld, J.; Steinbusch, H.; Verhofstad, A. E. R.; Said, S.; Brown, M. Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antiserum to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J. Neurocytol. 1981, 10, 963-980.
110. Green, T; Dockray, G. J. Calcitonin gene-related peptide and substance P in afferents to the upper gastrointestinal tract in the rat. Neurosci. Lett. 1987, 76, 151-156.
111. Sternini, C.; Reeve, J.R,; jr.Brecha, N. Distribution and characterization of calcitonin gene-related peptide immunreactivity in the digestive system of normal and capsaicin-treated rats. Gastroenrology 1987, 93, 852-862.
112. Raybould, H.E.; Sternini, C.; Wysselein, V.E.; Yoneda, M.; Holzer, P. Selective ablation of sensory neurons containing CGRP attenuates gastric hyperemic response to acid. Peptides 1992, 13, 249-254.
113. Suzuki, T.; Kagoshima, M.; Shibata, M.; Inaba, H.; Onodera, S, Yamamura, T.; Shimada, H. Effects of several denervation procedures on distribution of calcitonin gene-related peptide and substance P immunrecative in rat stomach. Dig. Dis. Sci. 1997, 42/6, 1242-1254.
114. Renzi, D.; Santicioli, P.; Maggi, C.A.; Surrenti, C.; Pradelles, P.; Meli, A. Capsaicin-induced relapse of substance P-like immunoreactivity from the guinea pig stomach in vitro and in vivo. Neurosci. Lett. 1988, 92, 254-258.
115. Kwok, Y.N.; McInthos, C. H. S. Release of substance P-like immunoreactivity from the vascularly perfused rat stomach. Eur. J. Pharmacol. 1990, 180, 201-207.
116. Sternini, C. Enteric and visceral afferent CGRP neurons. Target of innervation and differential expression patterns. Ann. N Y. Acad. Sci. 1992, 657, 181-193.
117. Lambrecht, N.; Burchert, M.R.M.; Müller, K.M.; Peskar, B.M. Role of calcitonin gene related peptide and nitric oxide in the gastroprotective effect of capsaicin in the rat. Gastroenterology 1993, 14, 1371-1380.
118. Brzozowski, T., Drozdovicz, D., Szlachcic, A., Pytko-Polonczyk, J., Majka, J., Konturek, S.J. Role of nitric oxide and prostaglandins in gastroprotection induced by capsaicin and papaverine. Digestion 1993, 54, 24-31.
119. Evangelista, S.; Tramontana, M.; Maggi, C.A. Pharmacologial evidence for the involvement of multiple calcitonin gene-related peptide receptors in the antisecretory and antiulcer effect of CGRP in rat stomach. Life Sci. 1991, 50, 13-18.
120. Manela, F.D.; Ren, J.; Gao, J.; McGuigan, J.E.; Harty, R.F. Calcitonin gene-related peptide modulates acid-mediated release of somatostatin and gastrin in 2-h pylorus ligated rat antrum. Gastroenterology, 1995, 109, 701-706.
121. Katori, M.; Ohno, T.; Nishiyama, K. Interaction of substance P and leukotriene C4 in ethanol-induced mucosal injury of rat stomach. Regul. Pept. 1993, 46, 241-243.
122. Matsumoto, J.; Takeuchi,K.; Okabe, S. Characterization of gastric mucosal blood flow response induced by intragastric capsaicin in rats. Jpn. J. Pharmacol. 1991, 57, 205-213
123. Karmeli, F.; Eliakim, R.; Okon, E.; Rachmilewitz, D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991, 100, 1206-1216.
124. Brain, S.D.; Williams, T.J.; Tippins, J.B.; Morris, H.B.; MacIntire, I. Calcitonin gene-related peptide is a potent vasodilator. Nature, 1985, 313, 54-56.
125. Whittle, B.J.R.; Lopez-Belmonte, J.; Reed, D.D. Modulation of vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 1989, 98, 646-652.
126. Stroff, T.; Plate, S.; Seyed Ebrahim, J.; Ehrich, K. K.; Respondek, M.; Peskar, B. M. Tacykinin-induced increase in gastric mucosal resistance: role of primary afferent neurons, CGRP, and NO. Am. J. Physiol. 1996, 271, G1017-G1027.
127. Fujimya, M.; Inui, A. Peptidergic regulation of gastrointestinal motility of rodents. Peptides, 2000, 21, 1565-1582.
128. 2: a probable explanation of cytoprotection. Dig. Dis. Sci. 1985, 30, 43-46.
129. 2 adrenoceptors. Dig. Dis Sci. 1987, 32, 1100-1107.
130. Nikolorakis, K.E.; Almeida, O.F.X.; Herz, A. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor. Brain Res. 1986, 399, 152-155.
131. Tsigos, C.; Chrousos, G.P hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53, 865-871.
132. Laszlo, F.; Karacsony, G.; Pavo, I.; Varga, C.; Rojik, I.; Laszlo, F.A. Aggressive role of vasopressin in development of different gastric lesions in rats. Eur. J. Pharmacol. 1994, 258 (1-2), 15-22.
133. Kang, J. C.; Yeoh, K. G.; Chia, H.P.; Lee, H. P.; Chia, Y. W.; Guan, R.; Yap, I. Dig. Chili-protective factor against peptic ulcer? Dig. Dis. Sci. 1995, 40, 576-579.